Acorda Therapeutics Inc Empfehlungs-Mittelwert
Was ist das Empfehlungs-Mittelwert von Acorda Therapeutics Inc?
Empfehlungs-Mittelwert von Acorda Therapeutics Inc ist 2.33
Was ist die Definition von Empfehlungs-Mittelwert?
Der empfohlene Mittelwert ist der Durchschnitt der Analystenbewertungen der Aktie von 1,0 (starker Kauf) bis 5,0 (starker Verkauf).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Empfehlungs-Mittelwert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit empfehlungs-mittelwert ähnlich Acorda Therapeutics Inc
- Fox hat Empfehlungs-Mittelwert von 2.32
- Dicks Sporting Goods hat Empfehlungs-Mittelwert von 2.32
- Fortinet Inc hat Empfehlungs-Mittelwert von 2.32
- Oracle hat Empfehlungs-Mittelwert von 2.32
- Verizon Communications Inc hat Empfehlungs-Mittelwert von 2.32
- Bank Of New York Mellon Corp hat Empfehlungs-Mittelwert von 2.32
- Acorda Therapeutics Inc hat Empfehlungs-Mittelwert von 2.33
- APA hat Empfehlungs-Mittelwert von 2.34
- Huntington Bancshares hat Empfehlungs-Mittelwert von 2.35
- Pentair plc hat Empfehlungs-Mittelwert von 2.35
- Banco Bilbao Vizcaya Argentaria S.A hat Empfehlungs-Mittelwert von 2.35
- Healthcare Realty Trust Inc hat Empfehlungs-Mittelwert von 2.36
- Azul S.A hat Empfehlungs-Mittelwert von 2.36